STAT Plus: Watch: CEO Daniel O’Day says Gilead is in a ‘sweet spot.’ What’s next?
What’s Gilead going to buy?
That’s the single, persistent question Daniel O’Day has faced in his first months on the job as CEO of Gilead Sciences.
Continue to STAT Plus to read the full story…
